A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response

Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2016-08, Vol.35 (33), p.4399-4406
Hauptverfasser: Melo, C A, Léveillé, N, Rooijers, K, Wijchers, P J, Geeven, G, Tal, A, Melo, S A, de Laat, W, Agami, R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4406
container_issue 33
container_start_page 4399
container_title Oncogene
container_volume 35
creator Melo, C A
Léveillé, N
Rooijers, K
Wijchers, P J
Geeven, G
Tal, A
Melo, S A
de Laat, W
Agami, R
description Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 ( linc-475 ). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.
doi_str_mv 10.1038/onc.2015.502
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1815705270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A460994056</galeid><sourcerecordid>A460994056</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-19eac483ed33ff6d0bb97aed0a6d9455aea66ad07c3917477ebe8454c27369e33</originalsourceid><addsrcrecordid>eNqNks2LFDEQxYMo7rh68ywBLx62x3yncxwWXYVFQfQc0kn1mKUnmU26D_73ppn1k0Ukh8DLr16lqIfQc0q2lPD-dU5-ywiVW0nYA7ShQqtOSiMeog0xknSGcXaGntR6QwjRhrDH6IwprRWVZoNgh4-Sd0NeUsCQvrrkoeAC-5gT9jnNJU8VOzzltMcxzVD2kKLHqbXNITbx04dd42-XWCDgMZfVD9e5QK1Nr8ecKjxFj0Y3VXh2d5-jL2_ffL58111_vHp_ubvuvGR87qgB50XPIXA-jiqQYTDaQSBOBSOkdOCUcoFozw3VQmsYoBdSeKa5MsD5OXp18j2WfLtAne0hVg_T5BLkpVraU6mJZJr8D8r6XhttGvryL_QmLyW1QSxTgspeEcX-Ra1erOeql7-ovZvAxjTmuTi_trY7oYgxgkjVqO09VDsBDrFtBcbY9D8KLk4FvuRaC4z2WOLBlW-WErvGxLZ92TUmtsWk4S_u_roMBwg_4R-5aEB3Amp7Snsovw1zn-F30O3Dew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1812283685</pqid></control><display><type>article</type><title>A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response</title><source>MEDLINE</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Melo, C A ; Léveillé, N ; Rooijers, K ; Wijchers, P J ; Geeven, G ; Tal, A ; Melo, S A ; de Laat, W ; Agami, R</creator><creatorcontrib>Melo, C A ; Léveillé, N ; Rooijers, K ; Wijchers, P J ; Geeven, G ; Tal, A ; Melo, S A ; de Laat, W ; Agami, R</creatorcontrib><description>Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 ( linc-475 ). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/onc.2015.502</identifier><identifier>PMID: 26776159</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/89 ; 38 ; 38/91 ; 45/15 ; 45/90 ; 631/208/199 ; 631/337/384 ; 631/67/581 ; Antisense RNA ; Apoptosis ; Cell Biology ; Cell cycle ; Chromatin ; Cyclin-dependent kinase inhibitor p21 ; Cyclin-Dependent Kinase Inhibitor p21 - genetics ; DNA-directed RNA polymerase ; Enhancer Elements, Genetic - physiology ; G1 Phase Cell Cycle Checkpoints ; Gene regulation ; Genes ; Genetic aspects ; Genomes ; Genomics ; Human Genetics ; Humans ; Internal Medicine ; Ionizing radiation ; Kinases ; Medicine ; Medicine &amp; Public Health ; Oncology ; p53 Protein ; Promoter Regions, Genetic ; Ribonucleic acid ; RNA ; RNA polymerase ; RNA Polymerase II - metabolism ; RNA, Long Noncoding - physiology ; short-communication ; Stress analysis ; Temperature effects ; Transcription (Genetics) ; Transcription activation ; Tumor proteins ; Tumor suppressor genes ; Tumor Suppressor Protein p53 - physiology ; Tumors</subject><ispartof>Oncogene, 2016-08, Vol.35 (33), p.4399-4406</ispartof><rights>Macmillan Publishers Limited 2016</rights><rights>COPYRIGHT 2016 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Aug 18, 2016</rights><rights>Macmillan Publishers Limited 2016.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-19eac483ed33ff6d0bb97aed0a6d9455aea66ad07c3917477ebe8454c27369e33</citedby><cites>FETCH-LOGICAL-c523t-19eac483ed33ff6d0bb97aed0a6d9455aea66ad07c3917477ebe8454c27369e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26776159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melo, C A</creatorcontrib><creatorcontrib>Léveillé, N</creatorcontrib><creatorcontrib>Rooijers, K</creatorcontrib><creatorcontrib>Wijchers, P J</creatorcontrib><creatorcontrib>Geeven, G</creatorcontrib><creatorcontrib>Tal, A</creatorcontrib><creatorcontrib>Melo, S A</creatorcontrib><creatorcontrib>de Laat, W</creatorcontrib><creatorcontrib>Agami, R</creatorcontrib><title>A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><description>Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 ( linc-475 ). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.</description><subject>13/89</subject><subject>38</subject><subject>38/91</subject><subject>45/15</subject><subject>45/90</subject><subject>631/208/199</subject><subject>631/337/384</subject><subject>631/67/581</subject><subject>Antisense RNA</subject><subject>Apoptosis</subject><subject>Cell Biology</subject><subject>Cell cycle</subject><subject>Chromatin</subject><subject>Cyclin-dependent kinase inhibitor p21</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - genetics</subject><subject>DNA-directed RNA polymerase</subject><subject>Enhancer Elements, Genetic - physiology</subject><subject>G1 Phase Cell Cycle Checkpoints</subject><subject>Gene regulation</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Ionizing radiation</subject><subject>Kinases</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Oncology</subject><subject>p53 Protein</subject><subject>Promoter Regions, Genetic</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA polymerase</subject><subject>RNA Polymerase II - metabolism</subject><subject>RNA, Long Noncoding - physiology</subject><subject>short-communication</subject><subject>Stress analysis</subject><subject>Temperature effects</subject><subject>Transcription (Genetics)</subject><subject>Transcription activation</subject><subject>Tumor proteins</subject><subject>Tumor suppressor genes</subject><subject>Tumor Suppressor Protein p53 - physiology</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNks2LFDEQxYMo7rh68ywBLx62x3yncxwWXYVFQfQc0kn1mKUnmU26D_73ppn1k0Ukh8DLr16lqIfQc0q2lPD-dU5-ywiVW0nYA7ShQqtOSiMeog0xknSGcXaGntR6QwjRhrDH6IwprRWVZoNgh4-Sd0NeUsCQvrrkoeAC-5gT9jnNJU8VOzzltMcxzVD2kKLHqbXNITbx04dd42-XWCDgMZfVD9e5QK1Nr8ecKjxFj0Y3VXh2d5-jL2_ffL58111_vHp_ubvuvGR87qgB50XPIXA-jiqQYTDaQSBOBSOkdOCUcoFozw3VQmsYoBdSeKa5MsD5OXp18j2WfLtAne0hVg_T5BLkpVraU6mJZJr8D8r6XhttGvryL_QmLyW1QSxTgspeEcX-Ra1erOeql7-ovZvAxjTmuTi_trY7oYgxgkjVqO09VDsBDrFtBcbY9D8KLk4FvuRaC4z2WOLBlW-WErvGxLZ92TUmtsWk4S_u_roMBwg_4R-5aEB3Amp7Snsovw1zn-F30O3Dew</recordid><startdate>20160818</startdate><enddate>20160818</enddate><creator>Melo, C A</creator><creator>Léveillé, N</creator><creator>Rooijers, K</creator><creator>Wijchers, P J</creator><creator>Geeven, G</creator><creator>Tal, A</creator><creator>Melo, S A</creator><creator>de Laat, W</creator><creator>Agami, R</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20160818</creationdate><title>A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response</title><author>Melo, C A ; Léveillé, N ; Rooijers, K ; Wijchers, P J ; Geeven, G ; Tal, A ; Melo, S A ; de Laat, W ; Agami, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-19eac483ed33ff6d0bb97aed0a6d9455aea66ad07c3917477ebe8454c27369e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>13/89</topic><topic>38</topic><topic>38/91</topic><topic>45/15</topic><topic>45/90</topic><topic>631/208/199</topic><topic>631/337/384</topic><topic>631/67/581</topic><topic>Antisense RNA</topic><topic>Apoptosis</topic><topic>Cell Biology</topic><topic>Cell cycle</topic><topic>Chromatin</topic><topic>Cyclin-dependent kinase inhibitor p21</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - genetics</topic><topic>DNA-directed RNA polymerase</topic><topic>Enhancer Elements, Genetic - physiology</topic><topic>G1 Phase Cell Cycle Checkpoints</topic><topic>Gene regulation</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Ionizing radiation</topic><topic>Kinases</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Oncology</topic><topic>p53 Protein</topic><topic>Promoter Regions, Genetic</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA polymerase</topic><topic>RNA Polymerase II - metabolism</topic><topic>RNA, Long Noncoding - physiology</topic><topic>short-communication</topic><topic>Stress analysis</topic><topic>Temperature effects</topic><topic>Transcription (Genetics)</topic><topic>Transcription activation</topic><topic>Tumor proteins</topic><topic>Tumor suppressor genes</topic><topic>Tumor Suppressor Protein p53 - physiology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melo, C A</creatorcontrib><creatorcontrib>Léveillé, N</creatorcontrib><creatorcontrib>Rooijers, K</creatorcontrib><creatorcontrib>Wijchers, P J</creatorcontrib><creatorcontrib>Geeven, G</creatorcontrib><creatorcontrib>Tal, A</creatorcontrib><creatorcontrib>Melo, S A</creatorcontrib><creatorcontrib>de Laat, W</creatorcontrib><creatorcontrib>Agami, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melo, C A</au><au>Léveillé, N</au><au>Rooijers, K</au><au>Wijchers, P J</au><au>Geeven, G</au><au>Tal, A</au><au>Melo, S A</au><au>de Laat, W</au><au>Agami, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2016-08-18</date><risdate>2016</risdate><volume>35</volume><issue>33</issue><spage>4399</spage><epage>4406</epage><pages>4399-4406</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>Genome-wide chromatin studies identified the tumor suppressor p53 as both a promoter and an enhancer-binding transcription factor. As an enhancer factor, p53 can induce local production of enhancer RNAs, as well as transcriptional activation of distal neighboring genes. Beyond the regulation of protein-coding genes, p53 has the capacity to regulate long intergenic noncoding RNA molecules (lincRNAs); however, their importance to the p53 tumor suppressive function remains poorly characterized. Here, we identified and characterized a novel p53-bound intronic enhancer that controls the expression of its host, the lincRNA00475 ( linc-475 ). We demonstrate the requirement of linc-475 for the proper induction of a p53-dependent cell cycle inhibitory response. We further confirm the functional importance of linc-475 in the maintenance of CDKN1A/p21 levels, a cell cycle inhibitor and a major p53 target gene, following p53 activation. Interestingly, loss of linc-475 reduced the binding of both p53 and RNA polymerase II (RNAPII) to the promoter of p21, attenuating its transcription rate following p53 activation. Altogether, our data suggest a direct role of p53-bound enhancer domains in the activation of lincRNAs required for an efficient p53 transcriptional response.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>26776159</pmid><doi>10.1038/onc.2015.502</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2016-08, Vol.35 (33), p.4399-4406
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_miscellaneous_1815705270
source MEDLINE; Nature; Alma/SFX Local Collection
subjects 13/89
38
38/91
45/15
45/90
631/208/199
631/337/384
631/67/581
Antisense RNA
Apoptosis
Cell Biology
Cell cycle
Chromatin
Cyclin-dependent kinase inhibitor p21
Cyclin-Dependent Kinase Inhibitor p21 - genetics
DNA-directed RNA polymerase
Enhancer Elements, Genetic - physiology
G1 Phase Cell Cycle Checkpoints
Gene regulation
Genes
Genetic aspects
Genomes
Genomics
Human Genetics
Humans
Internal Medicine
Ionizing radiation
Kinases
Medicine
Medicine & Public Health
Oncology
p53 Protein
Promoter Regions, Genetic
Ribonucleic acid
RNA
RNA polymerase
RNA Polymerase II - metabolism
RNA, Long Noncoding - physiology
short-communication
Stress analysis
Temperature effects
Transcription (Genetics)
Transcription activation
Tumor proteins
Tumor suppressor genes
Tumor Suppressor Protein p53 - physiology
Tumors
title A p53-bound enhancer region controls a long intergenic noncoding RNA required for p53 stress response
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T03%3A29%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20p53-bound%20enhancer%20region%20controls%20a%20long%20intergenic%20noncoding%20RNA%20required%20for%20p53%20stress%20response&rft.jtitle=Oncogene&rft.au=Melo,%20C%20A&rft.date=2016-08-18&rft.volume=35&rft.issue=33&rft.spage=4399&rft.epage=4406&rft.pages=4399-4406&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/onc.2015.502&rft_dat=%3Cgale_proqu%3EA460994056%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1812283685&rft_id=info:pmid/26776159&rft_galeid=A460994056&rfr_iscdi=true